Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2912 participants.
Also called NCT02604264
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,912 participants
- Sponsor
- Pursuit Vascular, Inc.
- Registry
-
NCT02604264
-
- Other papers using this trial's data
- Dialysis Catheter-Related Bloodstream Infections: A Cluster-Randomized Trial of the ClearGuard HD Antimicrobial Barrier Cap
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT02604264. Randomized; no masking; primary purpose treatment. Start 2014-12 (actual); primary completion 2015-11 (actual). Results posted on 2017-05-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Product Evaluation for the Effectiveness of the ClearGuard™ HD End Cap
- Condition
- End Stage Renal Disease (ESRD)
- Intervention (Device)
- ClearGuard HD end cap
- Lead sponsor
- Pursuit Vascular, Inc.
- Collaborator
- Fresenius Medical Care North America
Record details
- Record id
cardio:ct-nct02604264- Content hash
eeaed44429b674f2edae4215f8bd033b2eb526ce917e8b7391a6c10576ae793f